Cargando…

Continuous renal replacement therapy in patients with HIV/AIDS

BACKGROUND: Acute kidney injury (AKI) is a common complication among human immunodeficiency virus (HIV)-infected patients resulting in increased morbidity and mortality. Continuous renal replacement therapy (CRRT) is a useful method and instrument in critically ill patients with fluid overload and m...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Hebing, Liu, Jingyuan, Pu, Lin, Hao, Jingjing, Yin, Ningning, Liu, Yufeng, Xiong, Haofeng, Li, Ang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066780/
https://www.ncbi.nlm.nih.gov/pubmed/32160882
http://dx.doi.org/10.1186/s12882-020-01754-4
_version_ 1783505309387456512
author Guo, Hebing
Liu, Jingyuan
Pu, Lin
Hao, Jingjing
Yin, Ningning
Liu, Yufeng
Xiong, Haofeng
Li, Ang
author_facet Guo, Hebing
Liu, Jingyuan
Pu, Lin
Hao, Jingjing
Yin, Ningning
Liu, Yufeng
Xiong, Haofeng
Li, Ang
author_sort Guo, Hebing
collection PubMed
description BACKGROUND: Acute kidney injury (AKI) is a common complication among human immunodeficiency virus (HIV)-infected patients resulting in increased morbidity and mortality. Continuous renal replacement therapy (CRRT) is a useful method and instrument in critically ill patients with fluid overload and metabolic disarray, especially in those who are unable to tolerate the intermittent hemodialysis. However, the epidemiology, influence factors of CRRT and mortality in patients with HIV/AIDS are still unclear in China. This study aims to study the HIV-infected patients admitted in Intensive Care Unit (ICU) and explore the influence factors correlated with CRRT and their prognosis. METHODS: We performed a retrospective case-control study in the ICU of the Beijing Ditan Hospital Capital Medical University. From June 1, 2005 to May 31, 2017, 225 cases were enrolled in this clinical study. RESULTS: 122 (54.2%) patients were diagnosed with AKI during their stay in ICU, the number and percentage of AKI stage 1, 2 and 3 were 38 (31.1%), 21(17.2%) and 63(51.7%), respectively. 26.2% of AKI patients received CRRT during the stay of ICU. 56.25% CRRT patients died in ICU. The 28-day mortality was 62.5%, and the 90-day mortality was 75%. By univariate logistics analysis, it showed that higher likelihood of diagnosis for respiratory failure (OR = 7.333,95% CI 1.467–36.664, p = 0.015), higher likelihood of diagnosis for septic shock (OR = 1.005,95% CI 1.001–1.01, p = 0.018), and higher likelihood to use vasoactive agents (OR = 10.667,95% CI 1.743–65.271, p = 0.001), longer mechanical ventilation duration (OR = 1.011,95% CI 1.002–1.019, p = 0.011), higher likelihood for diagnosis for PCP (OR = 7.50,95% CI 1.288–43.687, p = 0.025), higher SOFA score at ICU admission (OR = 1.183,95% CI 1.012–1.383, p = 0.035), longer duration of CRRT (OR = 1.014,95% CI 1.001–1.028, p = 0.034) contributed to a higher mortality at ICU. The Cox Analysis for the cumulative survival of AKI 3 patients between the CRRT and non-CRRT groups shows no significant differences (p = 0.595). CONCLUSIONS: There is a high incidence of AKI in HIV-infected patients admitted in our ICU. Patients with severe AKI were more prone to be admitted for CRRT and have a consequent poor prognosis.
format Online
Article
Text
id pubmed-7066780
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-70667802020-03-18 Continuous renal replacement therapy in patients with HIV/AIDS Guo, Hebing Liu, Jingyuan Pu, Lin Hao, Jingjing Yin, Ningning Liu, Yufeng Xiong, Haofeng Li, Ang BMC Nephrol Research Article BACKGROUND: Acute kidney injury (AKI) is a common complication among human immunodeficiency virus (HIV)-infected patients resulting in increased morbidity and mortality. Continuous renal replacement therapy (CRRT) is a useful method and instrument in critically ill patients with fluid overload and metabolic disarray, especially in those who are unable to tolerate the intermittent hemodialysis. However, the epidemiology, influence factors of CRRT and mortality in patients with HIV/AIDS are still unclear in China. This study aims to study the HIV-infected patients admitted in Intensive Care Unit (ICU) and explore the influence factors correlated with CRRT and their prognosis. METHODS: We performed a retrospective case-control study in the ICU of the Beijing Ditan Hospital Capital Medical University. From June 1, 2005 to May 31, 2017, 225 cases were enrolled in this clinical study. RESULTS: 122 (54.2%) patients were diagnosed with AKI during their stay in ICU, the number and percentage of AKI stage 1, 2 and 3 were 38 (31.1%), 21(17.2%) and 63(51.7%), respectively. 26.2% of AKI patients received CRRT during the stay of ICU. 56.25% CRRT patients died in ICU. The 28-day mortality was 62.5%, and the 90-day mortality was 75%. By univariate logistics analysis, it showed that higher likelihood of diagnosis for respiratory failure (OR = 7.333,95% CI 1.467–36.664, p = 0.015), higher likelihood of diagnosis for septic shock (OR = 1.005,95% CI 1.001–1.01, p = 0.018), and higher likelihood to use vasoactive agents (OR = 10.667,95% CI 1.743–65.271, p = 0.001), longer mechanical ventilation duration (OR = 1.011,95% CI 1.002–1.019, p = 0.011), higher likelihood for diagnosis for PCP (OR = 7.50,95% CI 1.288–43.687, p = 0.025), higher SOFA score at ICU admission (OR = 1.183,95% CI 1.012–1.383, p = 0.035), longer duration of CRRT (OR = 1.014,95% CI 1.001–1.028, p = 0.034) contributed to a higher mortality at ICU. The Cox Analysis for the cumulative survival of AKI 3 patients between the CRRT and non-CRRT groups shows no significant differences (p = 0.595). CONCLUSIONS: There is a high incidence of AKI in HIV-infected patients admitted in our ICU. Patients with severe AKI were more prone to be admitted for CRRT and have a consequent poor prognosis. BioMed Central 2020-03-11 /pmc/articles/PMC7066780/ /pubmed/32160882 http://dx.doi.org/10.1186/s12882-020-01754-4 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Guo, Hebing
Liu, Jingyuan
Pu, Lin
Hao, Jingjing
Yin, Ningning
Liu, Yufeng
Xiong, Haofeng
Li, Ang
Continuous renal replacement therapy in patients with HIV/AIDS
title Continuous renal replacement therapy in patients with HIV/AIDS
title_full Continuous renal replacement therapy in patients with HIV/AIDS
title_fullStr Continuous renal replacement therapy in patients with HIV/AIDS
title_full_unstemmed Continuous renal replacement therapy in patients with HIV/AIDS
title_short Continuous renal replacement therapy in patients with HIV/AIDS
title_sort continuous renal replacement therapy in patients with hiv/aids
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066780/
https://www.ncbi.nlm.nih.gov/pubmed/32160882
http://dx.doi.org/10.1186/s12882-020-01754-4
work_keys_str_mv AT guohebing continuousrenalreplacementtherapyinpatientswithhivaids
AT liujingyuan continuousrenalreplacementtherapyinpatientswithhivaids
AT pulin continuousrenalreplacementtherapyinpatientswithhivaids
AT haojingjing continuousrenalreplacementtherapyinpatientswithhivaids
AT yinningning continuousrenalreplacementtherapyinpatientswithhivaids
AT liuyufeng continuousrenalreplacementtherapyinpatientswithhivaids
AT xionghaofeng continuousrenalreplacementtherapyinpatientswithhivaids
AT liang continuousrenalreplacementtherapyinpatientswithhivaids